Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system
- PMID: 16570854
- PMCID: PMC7121733
- DOI: 10.1007/978-3-540-33397-5_1
Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system
Abstract
Encounters with neurotropic viruses result in varied outcomes ranging from encephalitis, paralytic poliomyelitis or other serious consequences to relatively benign infection. One of the principal factors that control the outcome of infection is the localized tissue response and subsequent immune response directed against the invading toxic agent. It is the role of the immune system to contain and control the spread of virus infection in the central nervous system (CNS), and paradoxically, this response may also be pathologic. Chemokines are potent proinflammatory molecules whose expression within virally infected tissues is often associated with protection and/or pathology which correlates with migration and accumulation of immune cells. Indeed, studies with a neurotropic murine coronavirus, mouse hepatitis virus (MHV), have provided important insight into the functional roles of chemokines and chemokine receptors in participating in various aspects of host defense as well as disease development within the CNS. This chapter will highlight recent discoveries that have provided insight into the diverse biologic roles of chemokines and their receptors in coordinating immune responses following viral infection of the CNS.
Similar articles
-
Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.Viral Immunol. 2019 Jan/Feb;32(1):25-37. doi: 10.1089/vim.2018.0073. Epub 2018 Aug 15. Viral Immunol. 2019. PMID: 30109979 Free PMC article. Review.
-
Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM.Immunol Res. 2007;39(1-3):160-72. doi: 10.1007/s12026-007-0079-y. Immunol Res. 2007. PMID: 17917063 Free PMC article. Review.
-
Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease.Viral Immunol. 2002;15(2):261-72. doi: 10.1089/08828240260066215. Viral Immunol. 2002. PMID: 12081011 Review.
-
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease.J Immunol. 1998 Jan 15;160(2):970-8. J Immunol. 1998. PMID: 9551936
-
Mouse hepatitis virus infection of the CNS: a model for defense, disease, and repair.Front Biosci. 2008 May 1;13:4393-406. doi: 10.2741/3012. Front Biosci. 2008. PMID: 18508518 Free PMC article.
Cited by
-
Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.Curr Opin Pharmacol. 2008 Aug;8(4):472-9. doi: 10.1016/j.coph.2008.05.002. Epub 2008 Jun 16. Curr Opin Pharmacol. 2008. PMID: 18562249 Free PMC article. Review.
-
Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease in BALB/c mice from encephalitis to flaccid paralysis and demyelination.J Neurovirol. 2010 Jul;16(4):279-93. doi: 10.3109/13550284.2010.497806. J Neurovirol. 2010. PMID: 20642316 Free PMC article.
-
Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production.J Virol. 2009 Sep;83(17):8604-15. doi: 10.1128/JVI.02477-08. Epub 2009 Jun 10. J Virol. 2009. PMID: 19515766 Free PMC article.
-
COVID-19 and the impact on Alzheimer's disease pathology.J Neurochem. 2024 Oct;168(10):3415-3429. doi: 10.1111/jnc.15985. Epub 2023 Oct 18. J Neurochem. 2024. PMID: 37850241 Review.
-
Non-invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo.Cell Microbiol. 2009 May;11(5):825-41. doi: 10.1111/j.1462-5822.2009.01298.x. Epub 2009 Feb 10. Cell Microbiol. 2009. PMID: 19215224 Free PMC article.
References
-
- Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A. 1999;96:6873–6878. doi: 10.1073/pnas.96.12.6873. - DOI - PMC - PubMed